Resources Contact Us Home
Modified leukotoxin protein

Image Number 10 for United States Patent #7790170.

The present invention provides nucleic acid sequences encoding a modified leukotoxin protein, wherein the modification comprises the removal of nucleic acid sequences encoding amino acids within hydrophobic transmembrane domains of full length leukotoxin protein, preferably from Mannheimia haemolytica. The modified leukotoxin proteins are useful in vaccine compositions effective against Mannheimia haemolytica in animals.

  Recently Added Patents
Acoustic measuring instrument
Frame syncrhonization in orthogonal frequency-division multiplexing systems
Device for increasing chip testing efficiency and method thereof
Composite filtration membranes and methods of preparation thereof
5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases
Multi-wired antenna for mobile apparatus
Medicament delivery device and a method of medicament delivery
  Randomly Featured Patents
Rotary shaft water seal device in hydraulic machine
Flame inhibiting and retarding chemical process and system for general use on multiple solid surfaces
Impurity doping apparatus
Connector for a gradient sequential compression system
Plasma sterilization indicator
Power-saving electronic watch and method for operating electronic watch
Implant system with resonant-driven actuator
Three-piece bridge joint
Information processing apparatus, method thereof, network system, record medium, and program
Connector device and connector